Metraipolis › archive › dc_2c3486d53ffc

Blood biomarkers predict conversion from cognitively stable to mild cognitive impairment or Alzheimer's disease in Down syndrome at 16-month follow-up in ABC-DS — Europe PMC PMID:42449162

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42449162
DOI
10.1002/alz.71659
License (as archived)
solo-consultazione
Archived
2026-10-18T14:13:33.870Z
SHA-256 of the archived text
510c26cdb476e40475915202f6c5d6e37bdf218b9aad05c5a8422ccba94dc15e
Stable URL of this page
https://metraipolis.com/documento/dc_2c3486d53ffc

How to cite

Blood biomarkers predict conversion from cognitively stable to mild cognitive impairment or Alzheimer's disease in Down syndrome at 16-month follow-up in ABC-DS — Europe PMC PMID:42449162 — Europe PMC (en), https://europepmc.org/article/MED/42449162 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2c3486d53ffc (Metraipolis archive dc_2c3486d53ffc, sha256 510c26cdb476e40475915202f6c5d6e37bdf218b9aad05c5a8422ccba94dc15e)
BibTeX
@misc{dc2c3486d53ffc,
  title = {Blood biomarkers predict conversion from cognitively stable to mild cognitive impairment or Alzheimer's disease in Down syndrome at 16-month follow-up in ABC-DS — Europe PMC PMID:42449162},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42449162},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2c3486d53ffc; sha256 510c26cdb476e40475915202f6c5d6e37bdf218b9aad05c5a8422ccba94dc15e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42449162. Agents can read the archived copy with the MCP tool read_document.